Centessa Repays Oxford Finance Loan, Simplifies Structure Post-Lilly Acquisition
CNTA has more than doubled off its 52-week low of $12.39 on elevated volume (3.9× avg).
Summary
Centessa Pharmaceuticals has repaid in full and terminated its Loan and Security Agreement with Oxford Finance. This action follows the finalization of its acquisition by Eli Lilly, which was confirmed by an 8-K filed earlier today. The termination simplifies Centessa's capital structure as it transitions under new ownership, marking a procedural but positive step after the multi-month acquisition process.
At the time of this announcement, CNTA was trading at $40.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.3B. The 52-week trading range was $12.39 to $40.56. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.